Advertisement|Remove ads.

Artelo Biosciences Inc. (ARTL) shares soared more than 21% in Tuesday’s pre-market trade after the company announced that it has regained compliance with Nasdaq’s listing requirements.
Artelo stated that the Nasdaq sent a letter confirming the company is in compliance with the exchange’s rule requiring a minimum of $2.5 million in stockholders’ equity and another rule requiring an annual shareholders’ meeting.
The company stated that, in accordance with Nasdaq’s listing rules, Artelo will be subject to a mandatory panel monitor for a period of one year from the date of this letter.
Retail sentiment on Stocktwits around Artelo Biosciences trended in the ‘bearish’ territory at the time of writing.
Get updates to this developing story directly on Stocktwits.
For updates and corrections, email newsroom[at]stocktwits[dot]com.